[go: up one dir, main page]

CN106800598B - Antibody preservation solution and preparation method thereof - Google Patents

Antibody preservation solution and preparation method thereof Download PDF

Info

Publication number
CN106800598B
CN106800598B CN201710071642.4A CN201710071642A CN106800598B CN 106800598 B CN106800598 B CN 106800598B CN 201710071642 A CN201710071642 A CN 201710071642A CN 106800598 B CN106800598 B CN 106800598B
Authority
CN
China
Prior art keywords
polypeptide
antibody
pro
gly
preservation solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201710071642.4A
Other languages
Chinese (zh)
Other versions
CN106800598A (en
Inventor
于志军
张希涛
韩艳萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Guiyu Biotechnology Co ltd
Original Assignee
Guangzhou Guiyu Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Guiyu Biotechnology Co ltd filed Critical Guangzhou Guiyu Biotechnology Co ltd
Priority to CN201710071642.4A priority Critical patent/CN106800598B/en
Publication of CN106800598A publication Critical patent/CN106800598A/en
Application granted granted Critical
Publication of CN106800598B publication Critical patent/CN106800598B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

本发明公开了一种抗体保存液,抗体保存液包括:缓冲液、4‑6%海藻糖、0.005‑0.01%叠氮钠、30%‑50%甘油、0.002‑0.0025%第一多肽、0.002‑0.0025%第二多肽,其中,缓冲液为pH7.0‑7.5、40‑100mmol/L Tris‑HCl缓冲液,海藻糖、叠氮钠、甘油、第一多肽、第二多肽的浓度均为质量比,第一多肽的氨基酸序列为Val‑Pro‑Thr‑Gly‑Ala‑Pro,第二多肽的氨基酸序列为Ile‑Pro‑Gly‑Pro‑Val‑Gly。本发明还公开一种抗体保存液的制备方法。本发明抗体保存液可在室温下长期保存抗体,且可使抗体保持较高的活性。The invention discloses an antibody preservation solution, which comprises: buffer solution, 4-6% trehalose, 0.005-0.01% sodium azide, 30%-50% glycerol, 0.002-0.0025% first polypeptide, 0.002% -0.0025% of the second polypeptide, wherein the buffer is pH7.0-7.5, 40-100mmol/L Tris-HCl buffer, the concentrations of trehalose, sodium azide, glycerol, the first polypeptide, and the second polypeptide All are mass ratios, the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala-Pro, and the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly. The invention also discloses a preparation method of the antibody preservation solution. The antibody preservation solution of the present invention can store the antibody at room temperature for a long time, and can keep the antibody with high activity.

Description

一种抗体保存液及其制备方法Antibody preservation solution and preparation method thereof

技术领域technical field

本发明涉及生物技术领域,特别是涉及一种抗体保存液及其制备方法。The invention relates to the field of biotechnology, in particular to an antibody preservation solution and a preparation method thereof.

背景技术Background technique

抗体指机体的免疫系统在抗原的刺激下,由B淋巴细胞分化成的浆细胞产生的、可与相应抗原发生特异性结合的免疫球蛋白。由于抗体能够特异、稳定地结合特异性抗原,因此被广泛应用。在抗体利用过程中,其保存得当与否,直接影响抗体的活性和使用效果,对于多数抗体而言,通常进行低温保存,利用此方式保存,由于抗体进行反复冻融,会导致抗体变性、多聚体产生,从而降低抗体活性。Antibodies refer to immunoglobulins produced by plasma cells differentiated from B lymphocytes under the stimulation of antigens by the body's immune system, which can specifically bind to corresponding antigens. Antibodies are widely used because they can specifically and stably bind to specific antigens. In the process of antibody utilization, whether it is properly stored or not directly affects the activity and use effect of the antibody. For most antibodies, it is usually stored at low temperature. If this method is used to store the antibody, due to repeated freezing and thawing of the antibody, the antibody will be denatured and more Aggregates are produced, thereby reducing antibody activity.

如何提供一种可在室温下长期保存的抗体保存液,是抗体应用领域亟待解决的问题之一。How to provide an antibody preservation solution that can be stored for a long time at room temperature is one of the problems to be solved urgently in the field of antibody application.

发明内容SUMMARY OF THE INVENTION

本发明主要解决的技术问题是提供一种抗体保存液及其制备方法,可在室温下长期保存抗体,且可使抗体保持较高的活性。The main technical problem to be solved by the present invention is to provide an antibody preservation solution and a preparation method thereof, which can preserve the antibody at room temperature for a long time, and can keep the antibody relatively active.

为解决上述技术问题,本发明提供一种抗体保存液,抗体保存液包括:缓冲液、4-6%海藻糖、0.005-0.01%叠氮钠、30%-50%甘油、0.002-0.0025%第一多肽、0.002-0.0025%第二多肽,其中,缓冲液为pH7.0-7.5、40-100mmol/L Tris-HCl缓冲液,海藻糖、叠氮钠、甘油、第一多肽、第二多肽的浓度均为质量比,第一多肽的氨基酸序列为Val-Pro-Thr-Gly-Ala-Pro,第二多肽的氨基酸序列为Ile-Pro-Gly-Pro-Val-Gly。In order to solve the above technical problems, the present invention provides an antibody preservation solution, the antibody preservation solution includes: buffer, 4-6% trehalose, 0.005-0.01% sodium azide, 30%-50% glycerol, 0.002-0.0025% One polypeptide, 0.002-0.0025% of the second polypeptide, wherein the buffer is pH7.0-7.5, 40-100mmol/L Tris-HCl buffer, trehalose, sodium azide, glycerol, the first polypeptide, the third The concentrations of the two polypeptides are all mass ratios, the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala-Pro, and the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.

其中,抗体保存液包括:缓冲液、4.5-5.5%海藻糖、0.006-0.009%叠氮钠、35%-45%甘油、0.0021-0.0024%第一多肽、0.0021-0.0024%第二多肽,缓冲液为pH7.0-7.5、45-90mmol/L Tris-HCl缓冲液,海藻糖、叠氮钠、甘油、第一多肽、第二多肽的浓度均为质量比,第一多肽的氨基酸序列为Val-Pro-Thr-Gly-Ala-Pro,第二多肽的氨基酸序列为Ile-Pro-Gly-Pro-Val-Gly。Wherein, the antibody preservation solution includes: buffer, 4.5-5.5% trehalose, 0.006-0.009% sodium azide, 35%-45% glycerol, 0.0021-0.0024% first polypeptide, 0.0021-0.0024% second polypeptide, The buffer is pH7.0-7.5, 45-90mmol/L Tris-HCl buffer. The concentrations of trehalose, sodium azide, glycerol, the first polypeptide and the second polypeptide are all mass ratios. The amino acid sequence is Val-Pro-Thr-Gly-Ala-Pro, and the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.

其中,抗体保存液包括:缓冲液、5%海藻糖、0.007%叠氮钠、40%甘油、0.0022%第一多肽、0.0022%第二多肽,缓冲液为pH7.2、50mmol/L Tris-HCl缓冲液,海藻糖、叠氮钠、甘油、第一多肽、第二多肽的浓度均为质量比,第一多肽的氨基酸序列为Val-Pro-Thr-Gly-Ala-Pro,第二多肽的氨基酸序列为Ile-Pro-Gly-Pro-Val-Gly。Among them, the antibody preservation solution includes: buffer, 5% trehalose, 0.007% sodium azide, 40% glycerol, 0.0022% first polypeptide, 0.0022% second polypeptide, and the buffer solution is pH7.2, 50mmol/L Tris -HCl buffer, the concentrations of trehalose, sodium azide, glycerol, the first polypeptide, and the second polypeptide are all mass ratios, and the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala-Pro, The amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.

其中,质量比为g/L。Among them, the mass ratio is g/L.

为解决上述技术问题,本发明提供一种抗体保存液的制备方法,包括以下步骤:在pH7.0-7.5、40-100mmol/L Tris-HCl缓冲液中加入4-6%海藻糖、0.005-0.01%叠氮钠、30%-50%甘油、0.002-0.0025%第一多肽、0.002-0.0025%第二多肽,混合均匀,制备得到抗体保存液;其中,海藻糖、叠氮钠、甘油、第一多肽、第二多肽的浓度均为质量比,第一多肽的氨基酸序列为Val-Pro-Thr-Gly-Ala-Pro,第二多肽的氨基酸序列为Ile-Pro-Gly-Pro-Val-Gly。In order to solve the above-mentioned technical problems, the present invention provides a preparation method of an antibody preservation solution, comprising the following steps: adding 4-6% trehalose, 0.005- 0.01% sodium azide, 30%-50% glycerol, 0.002-0.0025% first polypeptide, 0.002-0.0025% second polypeptide, mix well, and prepare the antibody preservation solution; among them, trehalose, sodium azide, glycerol , the concentrations of the first polypeptide and the second polypeptide are mass ratios, the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala-Pro, and the amino acid sequence of the second polypeptide is Ile-Pro-Gly -Pro-Val-Gly.

其中,抗体保存液包括:缓冲液、4.5-5.5%海藻糖、0.006-0.009%叠氮钠、35%-45%甘油、0.0021-0.0024%第一多肽、0.0021-0.0024%第二多肽;缓冲液为pH7.0-7.5、45-90mmol/L Tris-HCl缓冲液。Wherein, the antibody preservation solution includes: buffer, 4.5-5.5% trehalose, 0.006-0.009% sodium azide, 35%-45% glycerol, 0.0021-0.0024% first polypeptide, 0.0021-0.0024% second polypeptide; The buffer is pH7.0-7.5, 45-90mmol/L Tris-HCl buffer.

其中,抗体保存液包括:缓冲液、5%海藻糖、0.007%叠氮钠、40%甘油、0.0022%第一多肽、0.0022%第二多肽;缓冲液为pH7.2、50mmol/L Tris-HCl缓冲液。Among them, the antibody preservation solution includes: buffer, 5% trehalose, 0.007% sodium azide, 40% glycerol, 0.0022% first polypeptide, 0.0022% second polypeptide; the buffer solution is pH7.2, 50mmol/L Tris -HCl buffer.

其中,质量比为g/L。Among them, the mass ratio is g/L.

本发明的有益效果是:区别于现有技术的情况,本发明的抗体保存液包括:缓冲液、4-6%海藻糖、0.005-0.01%叠氮钠、30%-50%甘油、0.002-0.0025%第一多肽、0.002-0.0025%第二多肽,其中,缓冲液为pH7.0-7.5、40-100mmol/L Tris-HCl缓冲液,第一多肽的氨基酸序列为Val-Pro-Thr-Gly-Ala-Pro,第二多肽的氨基酸序列为Ile-Pro-Gly-Pro-Val-Gly。上述组分的保存液具有以下特点:可在室温下长期保存抗体,且抗体保持较高的活性,其中,室温为26-29℃,保存期限为7年以上;第一多肽和第二多肽的加入,可防止保存液中的物质水解、酶解,使保存液中的物质保持稳定,具体为,第一多肽用于防止水解,第二多肽用于防止蛋白酶解。The beneficial effects of the present invention are: different from the situation in the prior art, the antibody preservation solution of the present invention includes: buffer, 4-6% trehalose, 0.005-0.01% sodium azide, 30%-50% glycerol, 0.002- 0.0025% of the first polypeptide, 0.002-0.0025% of the second polypeptide, wherein the buffer is pH7.0-7.5, 40-100mmol/L Tris-HCl buffer, and the amino acid sequence of the first polypeptide is Val-Pro- Thr-Gly-Ala-Pro, the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly. The preservation solution of the above components has the following characteristics: the antibody can be stored for a long time at room temperature, and the antibody maintains a relatively high activity. The addition of the peptide can prevent the hydrolysis and enzymolysis of the substances in the preservation solution, and keep the substances in the preservation solution stable. Specifically, the first polypeptide is used to prevent hydrolysis, and the second polypeptide is used to prevent proteolysis.

具体实施方式Detailed ways

实施例1Example 1

抗体保存液的制备方法如下:在pH7.2、50mmol/L Tris-HCl缓冲液中加入5%海藻糖、0.007%叠氮钠、40%甘油、0.0022%第一多肽、0.0022%第二多肽,混合均匀,制备得到抗体保存液。其中,海藻糖、叠氮钠、甘油、第一多肽、第二多肽的浓度均为质量比,具体为g/L;第一多肽的氨基酸序列为Val-Pro-Thr-Gly-Ala-Pro,第二多肽的氨基酸序列为Ile-Pro-Gly-Pro-Val-Gly。The preparation method of the antibody preservation solution is as follows: add 5% trehalose, 0.007% sodium azide, 40% glycerol, 0.0022% first polypeptide, 0.0022% second polyamide to pH7.2, 50mmol/L Tris-HCl buffer Peptide, mix well, and prepare antibody preservation solution. Wherein, the concentrations of trehalose, sodium azide, glycerol, the first polypeptide and the second polypeptide are all mass ratios, specifically g/L; the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala -Pro, the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.

下面对不同方式保存的抗体的活性进行检测,以说明本实施例抗体保存液的效用。抗体保存方式有:采用实施例1制备的抗体保存液保存抗体;现有室温抗体保存液保存抗体;现有低温(-20℃)抗体保存液保存抗体。其中,抗体为生长激素单克隆抗体,各保存方式均保存抗体1年。对于抗体活性的检测,采用酶联免疫吸附剂测定(enzyme linkedimmunosorbent assay,ELISA)进行检测。The activity of the antibodies preserved in different ways is tested below to illustrate the utility of the antibody preservation solution of this embodiment. Antibody preservation methods are as follows: the antibody preservation solution prepared in Example 1 is used to preserve the antibody; the antibody is preserved in the existing room temperature antibody preservation solution; the antibody is preserved in the existing low temperature (-20° C.) antibody preservation solution. Among them, the antibody is a growth hormone monoclonal antibody, and the antibody is preserved for 1 year in each storage method. For the detection of antibody activity, enzyme-linked immunosorbent assay (ELISA) was used for detection.

检测方法具体为:将生长激素抗原用含5ppm Proclin300的0.05mol/L、pH9.6的碳酸钠-碳酸氢钠缓冲液进行稀释,以获得包被液,其中,包被液中生长激素抗原的浓度为10μg/ml;封闭液为含5.0g/L海藻糖、0.5%BSA的0.05mol/L、pH9.6的碳酸钠-碳酸氢钠缓冲液;在空白反应板中加入包被液90μl/孔,37℃温箱中孵育2h,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入封闭液200μl/孔,25℃孵育过夜,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入上述不同方式保存的抗体90μl/孔,37℃温箱中孵育1h,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入酶标抗体90μl/孔,37℃温箱中孵育1h,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入新鲜配制的显色液90μl/孔,避光置37℃温箱20min;加入硫酸终止反应;在酶标仪上测定450nm波长处各孔的吸光值。其中,不同方式保存的抗体的浓度相同,抗体的稀释度均为1:4000。The detection method is specifically: dilute the growth hormone antigen with 0.05mol/L, pH9.6 sodium carbonate-sodium bicarbonate buffer containing 5ppm Proclin300 to obtain a coating solution, wherein the growth hormone antigen in the coating solution is diluted. The concentration is 10 μg/ml; the blocking solution is 0.05 mol/L sodium carbonate-sodium bicarbonate buffer containing 5.0 g/L trehalose, 0.5% BSA, pH 9.6; 90 μl/L of coating solution is added to the blank reaction plate Well, incubate at 37°C for 2 h, discard the residual liquid, wash three times with washing solution PBST on a plate washer, and pat dry; add 200 μl/well of blocking solution, incubate at 25 °C overnight, discard the residual liquid, and wash the plate. Wash 3 times with washing solution PBST on the machine, and pat dry; add 90 μl/well of the above-preserved antibodies in different ways, incubate in a 37 °C incubator for 1 h, discard the residual liquid, wash 3 times with washing solution PBST on the plate washer, and pat dry ; Add 90 μl/well of enzyme-labeled antibody, incubate in a 37°C incubator for 1 h, discard the residual liquid, wash 3 times with washing solution PBST on a plate washer, and pat dry; add 90 μl/well of freshly prepared chromogenic solution, protect from light Incubate at 37°C for 20min; add sulfuric acid to stop the reaction; measure the absorbance of each well at 450nm wavelength on a microplate reader. Among them, the concentrations of the antibodies stored in different ways were the same, and the dilution of the antibodies was 1:4000.

检测结果:实施例1制备的抗体保存液保存的抗体的吸光值为1.9,现有室温抗体保存液保存的抗体的吸光值为0.5,现有低温(-20℃)抗体保存液保存的抗体的吸光值为1.1。Test results: the absorbance value of the antibody preserved in the antibody preservation solution prepared in Example 1 was 1.9, the absorbance value of the antibody preserved in the existing room temperature antibody preservation solution was 0.5, and the absorbance value of the antibody preserved in the existing low temperature (-20°C) antibody preservation solution was 0.5. The absorbance value was 1.1.

根据检测结果,说明在同等条件下,实施例1制备的抗体保存液保存的抗体的活性高于其他方式保存的抗体的活性。According to the test results, under the same conditions, the activity of the antibody preserved in the antibody preservation solution prepared in Example 1 is higher than that of the antibody preserved in other ways.

实施例2Example 2

抗体保存液的制备方法如下:在pH7.2、50mmol/L Tris-HCl缓冲液中加入5.3%海藻糖、0.008%叠氮钠、43%甘油、0.0023%第一多肽、0.0023%第二多肽,混合均匀,制备得到抗体保存液。其中,海藻糖、叠氮钠、甘油、第一多肽、第二多肽的浓度均为质量比,具体为g/L;第一多肽的氨基酸序列为Val-Pro-Thr-Gly-Ala-Pro,第二多肽的氨基酸序列为Ile-Pro-Gly-Pro-Val-Gly。The preparation method of the antibody preservation solution is as follows: add 5.3% trehalose, 0.008% sodium azide, 43% glycerol, 0.0023% first polypeptide, 0.0023% second most to pH7.2, 50mmol/L Tris-HCl buffer Peptide, mix well, and prepare antibody preservation solution. Wherein, the concentrations of trehalose, sodium azide, glycerol, the first polypeptide and the second polypeptide are all mass ratios, specifically g/L; the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala -Pro, the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.

下面对不同方式保存的抗体的活性进行检测,以说明本实施例抗体保存液的效用。抗体保存方式有:采用实施例2制备的抗体保存液保存抗体;现有室温抗体保存液保存抗体;现有低温(-20℃)抗体保存液保存抗体。其中,抗体为生长激素单克隆抗体,各保存方式均保存抗体1年。对于抗体活性的检测,采用酶联免疫吸附剂测定进行检测。The activity of the antibodies preserved in different ways is tested below to illustrate the utility of the antibody preservation solution of this embodiment. Antibody preservation methods are as follows: the antibody preservation solution prepared in Example 2 is used to preserve the antibody; the existing room temperature antibody preservation solution is used to preserve the antibody; the existing low temperature (-20° C.) antibody preservation solution is used to preserve the antibody. Among them, the antibody is a growth hormone monoclonal antibody, and the antibody is preserved for 1 year in each storage method. For the detection of antibody activity, enzyme-linked immunosorbent assay was used for detection.

检测方法具体为:将生长激素抗原用含5ppm Proclin300的0.05mol/L、pH9.6的碳酸钠-碳酸氢钠缓冲液进行稀释,以获得包被液,其中,包被液中生长激素抗原的浓度为10μg/ml;封闭液为含5.0g/L海藻糖、0.5%BSA的0.05mol/L、pH9.6的碳酸钠-碳酸氢钠缓冲液;在空白反应板中加入包被液90μl/孔,37℃温箱中孵育2h,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入封闭液200μl/孔,25℃孵育过夜,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入上述不同方式保存的抗体90μl/孔,37℃温箱中孵育1h,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入酶标抗体90μl/孔,37℃温箱中孵育1h,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入新鲜配制的显色液90μl/孔,避光置37℃温箱20min;加入硫酸终止反应;在酶标仪上测定450nm波长处各孔的吸光值。其中,不同方式保存的抗体的浓度相同,抗体的稀释度均为1:4000。The detection method is specifically: dilute the growth hormone antigen with 0.05mol/L, pH9.6 sodium carbonate-sodium bicarbonate buffer containing 5ppm Proclin300 to obtain a coating solution, wherein the growth hormone antigen in the coating solution is diluted. The concentration is 10 μg/ml; the blocking solution is 0.05 mol/L sodium carbonate-sodium bicarbonate buffer containing 5.0 g/L trehalose, 0.5% BSA, pH 9.6; 90 μl/L of coating solution is added to the blank reaction plate Well, incubate at 37°C for 2 h, discard the residual liquid, wash three times with washing solution PBST on a plate washer, and pat dry; add 200 μl/well of blocking solution, incubate at 25 °C overnight, discard the residual liquid, and wash the plate. Wash 3 times with washing solution PBST on the machine, and pat dry; add 90 μl/well of the above-preserved antibodies in different ways, incubate at 37 °C for 1 h, discard the residual liquid, wash 3 times with washing solution PBST on the plate washer, and pat dry ; Add 90 μl/well of enzyme-labeled antibody, incubate in a 37°C incubator for 1 h, discard the residual liquid, wash 3 times with washing solution PBST on a plate washer, and pat dry; add 90 μl/well of freshly prepared chromogenic solution, protect from light Incubate at 37°C for 20min; add sulfuric acid to stop the reaction; measure the absorbance of each well at 450nm wavelength on a microplate reader. Among them, the concentrations of the antibodies stored in different ways were the same, and the dilution of the antibodies was 1:4000.

检测结果:实施例2制备的抗体保存液保存的抗体的吸光值为1.95,现有室温抗体保存液保存的抗体的吸光值为0.5,现有低温(-20℃)抗体保存液保存的抗体的吸光值为1.1。Test results: the absorbance value of the antibody preserved in the antibody preservation solution prepared in Example 2 was 1.95, the absorbance value of the antibody preserved in the existing room temperature antibody preservation solution was 0.5, and the absorbance value of the antibody preserved in the existing low temperature (-20°C) antibody preservation solution was 0.5. The absorbance value was 1.1.

根据检测结果,说明在同等条件下,实施例2制备的抗体保存液保存的抗体的活性高于其他方式保存的抗体的活性。According to the test results, under the same conditions, the activity of the antibody preserved in the antibody preservation solution prepared in Example 2 is higher than that of the antibody preserved in other ways.

对比例1Comparative Example 1

抗体保存液的制备方法如下:在pH7.2、50mmol/L Tris-HCl缓冲液中加入5%海藻糖、0.007%叠氮钠、40%甘油、0.0022%第一多肽,混合均匀,制备得到抗体保存液。其中,海藻糖、叠氮钠、甘油、第一多肽的浓度均为质量比,具体为g/L;第一多肽的氨基酸序列为Val-Pro-Thr-Gly-Ala-Pro。The preparation method of the antibody preservation solution is as follows: add 5% trehalose, 0.007% sodium azide, 40% glycerol, 0.0022% first polypeptide to pH7.2, 50mmol/L Tris-HCl buffer, mix well, and prepare Antibody preservation solution. Wherein, the concentrations of trehalose, sodium azide, glycerol, and the first polypeptide are all mass ratios, specifically g/L; the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala-Pro.

对比例2Comparative Example 2

抗体保存液的制备方法如下:在pH7.2、50mmol/L Tris-HCl缓冲液中加入5%海藻糖、0.007%叠氮钠、40%甘油、0.0022%第二多肽,混合均匀,制备得到抗体保存液。其中,海藻糖、叠氮钠、甘油、第二多肽的浓度均为质量比,具体为g/L;第二多肽的氨基酸序列为Ile-Pro-Gly-Pro-Val-Gly。The preparation method of the antibody preservation solution is as follows: add 5% trehalose, 0.007% sodium azide, 40% glycerol, 0.0022% second polypeptide to pH7.2, 50mmol/L Tris-HCl buffer, mix well, and prepare Antibody preservation solution. Wherein, the concentrations of trehalose, sodium azide, glycerol, and the second polypeptide are all mass ratios, specifically g/L; the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.

下面对不同抗体保存液保存的抗体的活性进行检测,以说明本发明抗体保存液的效用。抗体保存液有:实施例1制备的抗体保存液;实施例2制备的抗体保存液;对比例1制备的抗体保存液;对比例2制备的抗体保存液。其中,保存的抗体为生长激素单克隆抗体,各抗体保存液保存抗体1年。对于抗体活性的检测,采用酶联免疫吸附剂测定进行检测。The activity of the antibodies preserved in different antibody preservation solutions is tested below to illustrate the utility of the antibody preservation solution of the present invention. The antibody preservation solution includes: the antibody preservation solution prepared in Example 1; the antibody preservation solution prepared in Example 2; the antibody preservation solution prepared in Comparative Example 1; and the antibody preservation solution prepared in Comparative Example 2. Among them, the preserved antibody is growth hormone monoclonal antibody, and each antibody preservation solution preserves the antibody for 1 year. For the detection of antibody activity, enzyme-linked immunosorbent assay was used for detection.

检测方法具体为:将生长激素抗原用含5ppm Proclin300的0.05mol/L、pH9.6的碳酸钠-碳酸氢钠缓冲液进行稀释,以获得包被液,其中,包被液中生长激素抗原的浓度为10μg/ml;封闭液为含5.0g/L海藻糖、0.5%BSA的0.05mol/L、pH9.6的碳酸钠-碳酸氢钠缓冲液;在空白反应板中加入包被液90μl/孔,37℃温箱中孵育2h,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入封闭液200μl/孔,25℃孵育过夜,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入上述不同保存液保存的抗体90μl/孔,37℃温箱中孵育1h,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入酶标抗体90μl/孔,37℃温箱中孵育1h,倒去残液,在洗板机上用洗涤液PBST洗涤3次,拍干;加入新鲜配制的显色液90μl/孔,避光置37℃温箱20min;加入硫酸终止反应;在酶标仪上测定450nm波长处各孔的吸光值。其中,不同保存液保存的抗体的浓度相同,抗体的稀释度均为1:4000。The detection method is specifically: dilute the growth hormone antigen with 0.05mol/L, pH9.6 sodium carbonate-sodium bicarbonate buffer containing 5ppm Proclin300 to obtain a coating solution, wherein the growth hormone antigen in the coating solution is diluted. The concentration is 10 μg/ml; the blocking solution is 0.05 mol/L sodium carbonate-sodium bicarbonate buffer containing 5.0 g/L trehalose, 0.5% BSA, pH 9.6; 90 μl/L of coating solution is added to the blank reaction plate Well, incubate at 37°C for 2 h, discard the residual liquid, wash three times with washing solution PBST on a plate washer, and pat dry; add 200 μl/well of blocking solution, incubate at 25 °C overnight, discard the residual liquid, and wash the plate. Wash 3 times with washing solution PBST on the machine, and pat dry; add 90 μl/well of the above-mentioned antibodies preserved in different preservation solutions, incubate at 37 °C for 1 h, discard the residual liquid, wash 3 times with washing solution PBST on the plate washer, and pat Dry; add 90 μl/well of enzyme-labeled antibody, incubate in a 37°C incubator for 1 h, discard the residual liquid, wash 3 times with washing solution PBST on a plate washer, and pat dry; add 90 μl/well of freshly prepared chromogenic solution to avoid The light was placed in a 37°C incubator for 20 min; sulfuric acid was added to stop the reaction; the absorbance of each well at a wavelength of 450 nm was measured on a microplate reader. Among them, the concentration of antibodies stored in different preservation solutions is the same, and the dilution of antibodies is 1:4000.

检测结果:实施例1制备的抗体保存液保存的抗体的吸光值为1.9,实施例2制备的抗体保存液保存的抗体的吸光值为1.95,对比例1制备的抗体保存液保存的抗体的吸光值为1.2,对比例2制备的抗体保存液保存的抗体的吸光值为1.26。Test results: the absorbance value of the antibody preserved in the antibody preservation solution prepared in Example 1 was 1.9, the absorbance value of the antibody preserved in the antibody preservation solution prepared in Example 2 was 1.95, and the absorbance value of the antibody preserved in the antibody preservation solution prepared in Comparative Example 1 was 1.95. The value was 1.2, and the absorbance value of the antibody preserved in the antibody preservation solution prepared in Comparative Example 2 was 1.26.

根据检测结果,说明在同等条件下,本发明制备的抗体保存液保存的抗体的活性高于其他抗体保存液保存的抗体的活性。According to the detection results, under the same conditions, the activity of the antibody preserved in the antibody preservation solution prepared by the present invention is higher than that of the antibody preserved in other antibody preservation solutions.

综上所述,本发明抗体保存液具有以下特点:可在室温下长期保存抗体,且抗体保持较高的活性,其中,室温为26-29℃,保存期限为7年以上;第一多肽和第二多肽的加入,可防止保存液中的物质水解、酶解,使保存液中的物质保持稳定,具体为,第一多肽用于防止水解,第二多肽用于防止蛋白酶解。To sum up, the antibody preservation solution of the present invention has the following characteristics: the antibody can be stored for a long time at room temperature, and the antibody maintains a relatively high activity, wherein the room temperature is 26-29°C, and the storage period is more than 7 years; the first polypeptide And the addition of the second polypeptide can prevent the hydrolysis and enzymolysis of the substances in the preservation solution, and keep the substances in the preservation solution stable. Specifically, the first polypeptide is used to prevent hydrolysis, and the second polypeptide is used to prevent proteolysis. .

以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作的等效结构或等效流程变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。The above descriptions are only the embodiments of the present invention, and do not limit the scope of the present invention. Any equivalent structure or equivalent process transformation made by using the contents of the description of the present invention, or directly or indirectly applied in other related technical fields, will not limit the scope of the invention. Similarly, it is included in the scope of patent protection of the present invention.

SEQUENCE LISTINGSEQUENCE LISTING

<110> 广州桂雨生物科技有限公司<110> Guangzhou Guiyu Biotechnology Co., Ltd.

<120> 一种抗体保存液及其制备方法<120> A kind of antibody preservation solution and preparation method thereof

<130><130>

<160> 2<160> 2

<170> PatentIn version 3.5<170> PatentIn version 3.5

<210> 1<210> 1

<211> 6<211> 6

<212> PRT<212> PRT

<213> 人工序列<213> Artificial sequences

<400> 1<400> 1

Val Pro Thr Gly Ala ProVal Pro Thr Gly Ala Pro

1 51 5

<210> 2<210> 2

<211> 6<211> 6

<212> PRT<212> PRT

<213> 人工序列<213> Artificial sequences

<400> 2<400> 2

Ile Pro Gly Pro Val GlyIle Pro Gly Pro Val Gly

1 51 5

Claims (6)

1. The antibody preservation solution is characterized by comprising a buffer solution, 4-6% of trehalose, 0.005-0.01% of sodium azide, 30-50% of glycerol, 0.002-0.0025% of first polypeptide and 0.002-0.0025% of second polypeptide, wherein the buffer solution is a Tris buffer solution with the pH value of 7.0-7.5 and the concentration of 40-100 mmol/L, the concentrations of the trehalose, the sodium azide, the glycerol, the first polypeptide and the second polypeptide are mass ratios, the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala-Pro, and the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.
2. The antibody preservation solution according to claim 1, wherein the antibody preservation solution comprises a buffer solution, 4.5-5.5% trehalose, 0.006-0.009% sodium azide, 35-45% glycerol, 0.0021-0.0024% first polypeptide and 0.0021-0.0024% second polypeptide, wherein the buffer solution is Tris-HCl buffer solution with pH7.0-7.5 and 45-90 mmol/L, the concentrations of the trehalose, the sodium azide, the glycerol, the first polypeptide and the second polypeptide are mass ratios, the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala-Pro, and the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.
3. The antibody preservation solution according to claim 2, wherein the antibody preservation solution comprises buffer solution, 5% trehalose, 0.007% sodium azide, 40% glycerol, 0.0022% first polypeptide and 0.0022% second polypeptide, wherein the buffer solution is Tris-HCl buffer solution with the pH value of 7.2 and the concentration of 50 mmol/L, the concentrations of the trehalose, the sodium azide, the glycerol, the first polypeptide and the second polypeptide are mass ratios, the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala-Pro, and the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.
4. A method for preparing an antibody preservation solution is characterized by comprising the following steps:
adding 4-6% trehalose, 0.005-0.01% sodium azide, 30-50% glycerol, 0.002-0.0025% first polypeptide and 0.002-0.0025% second polypeptide into Tris-HCl buffer solution (pH7.0-7.5) and 40-100 mmol/L mmol/HCl, and uniformly mixing to prepare an antibody preservation solution;
the concentration of the trehalose, the sodium azide, the glycerol, the first polypeptide and the concentration of the second polypeptide are mass ratio, the amino acid sequence of the first polypeptide is Val-Pro-Thr-Gly-Ala-Pro, and the amino acid sequence of the second polypeptide is Ile-Pro-Gly-Pro-Val-Gly.
5. The method for producing an antibody preservation solution according to claim 4, wherein the antibody preservation solution comprises: buffer solution, 4.5-5.5% trehalose, 0.006-0.009% sodium azide, 35% -45% glycerol, 0.0021-0.0024% first polypeptide, 0.0021-0.0024% second polypeptide;
wherein the buffer solution is Tris-HCl buffer solution with the pH value of 7.0-7.5 and the concentration of 45-90 mmol/L.
6. The method for producing an antibody preservation solution according to claim 5, wherein the antibody preservation solution comprises: buffer solution, 5% trehalose, 0.007% sodium azide, 40% glycerol, 0.0022% first polypeptide and 0.0022% second polypeptide;
wherein the buffer solution is Tris-HCl buffer solution with the pH value of 7.2 and the concentration of 50 mmol/L.
CN201710071642.4A 2017-02-09 2017-02-09 Antibody preservation solution and preparation method thereof Active CN106800598B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710071642.4A CN106800598B (en) 2017-02-09 2017-02-09 Antibody preservation solution and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710071642.4A CN106800598B (en) 2017-02-09 2017-02-09 Antibody preservation solution and preparation method thereof

Publications (2)

Publication Number Publication Date
CN106800598A CN106800598A (en) 2017-06-06
CN106800598B true CN106800598B (en) 2020-08-07

Family

ID=58987340

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710071642.4A Active CN106800598B (en) 2017-02-09 2017-02-09 Antibody preservation solution and preparation method thereof

Country Status (1)

Country Link
CN (1) CN106800598B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107602695B (en) * 2017-08-02 2020-06-19 深圳清华大学研究院 Fluorescent antibody preservation solution, kit and application thereof, and fluorescent antibody preservation method
CN114137202B (en) * 2022-01-12 2023-12-01 杭州隆基生物技术有限公司 Monoclonal antibody preservation solution

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007055284A1 (en) * 2005-11-11 2007-05-18 Toyo Boseki Kabushiki Kaisha Method for stabilization of biological molecule and composition
EP3721904B1 (en) * 2009-11-20 2021-10-13 Biocon Limited Formulations of t1h antibody
JP2011241206A (en) * 2010-04-23 2011-12-01 Arkray Inc Method for stabilizing labeled antibody
PL2714735T3 (en) * 2011-06-03 2022-02-21 Xoma Technology Ltd. Antibodies specific for tgf-beta
EA039663B1 (en) * 2012-05-03 2022-02-24 Амген Инк. Use of an anti-pcsk9 antibody for lowering serum cholesterol ldl and treating cholesterol related disorders
CN102879589A (en) * 2012-09-26 2013-01-16 中国人民解放军总医院 Human NT-proBNP preparation capable of stable preservation and preparation method thereof
CN103224542B (en) * 2013-04-17 2014-09-10 江苏澳格姆生物科技有限公司 Solution for antibody activity preservation under normal temperature and preparation method thereof
CA2930227C (en) * 2013-11-29 2021-09-28 Ares Trading S.A. A liquid formulation of a fusion protein comprising tnfr and fc region
CN105300966A (en) * 2015-11-17 2016-02-03 三诺生物传感股份有限公司 Preserving fluid and preparation method thereof
JOP20170017B1 (en) * 2016-01-25 2021-08-17 Amgen Res Munich Gmbh Pharmaceutical composition comprising bispecific antibody constructs

Also Published As

Publication number Publication date
CN106800598A (en) 2017-06-06

Similar Documents

Publication Publication Date Title
CN106800598B (en) Antibody preservation solution and preparation method thereof
CN108084257B (en) Human atrexin epitope peptide, antigen, antibody, kit and application
CN114544978A (en) IGF-1 detection kit, preparation method and detection method thereof
CN105695419A (en) Hybridoma cell strain 4C9 and anti-His tag protein monoclonal antibody produced by same
CN113289027B (en) A universal monoclonal antibody heat-resistant protective agent
CN101968481B (en) Method for detecting existence of heavy metal copper ion in sample and special kit thereof
CN113092758A (en) Double-antibody sandwich ELISA (enzyme-Linked immuno sorbent assay) detection kit for detecting trypsin analogue TrypLE (trypsin-like enzyme-linked immunosorbent assay), detection method and application
WO2022174570A1 (en) Method and kit for detecting amino-terminal pro-brain natriuretic peptide
US12486317B2 (en) Fungal (1,3)-beta-d glucan-directed monoclonal antibody, coding genes thereof, expression thereof and application thereof
CN104231052B (en) People Lp PLA2 epitope peptides, antigen, antibody, purposes and kit
CN103645318B (en) Staphylococcus aureus SpA5 mutant antigen-specific IgG antibody detection method and detection kit
CN108929374B (en) Human HBP epitope peptide, antigen, antibody, application and kit
CN114716539A (en) Antibody dilution protective agent
CN105606814A (en) Fluorescence immune chromatography test paper for detecting human ApoE-[epsilon]4 protein and preparation method thereof
CN105652010B (en) Detect fluorescence immune chromatography test paper of the albumen of people HSP90 α 1 and preparation method thereof
CN107973855A (en) Monoclonal antibody reacted with glycopeptide and application thereof
CN104422771B (en) Detect monoclonal antibody and the kit thereof of tick-brone encephalitis virus
Lugovskoy et al. Functional role of Bβ‐chain N‐terminal fragment in the fibrin polymerization process
CN111808188A (en) H7N9 influenza virus hemagglutinin protein ELISA kit
CN110437326A (en) The antigen epitope polypeptide and application thereof of bullous pemphigoid BP230 IgE antibody
CN103524629A (en) Complete antigen of AG22 polypeptide, preparation method and antibody thereof
CN102901816A (en) Method for yolk antibody-based enzyme-linked immunoadsordent assay (ELISA) detection of turtle systemic sepsis spherical viruses
CN113717255B (en) Polymyxin B and colistin hapten, artificial antigen, and preparation methods and applications thereof
CN106198989B (en) Detect the kit of prostate specific antigen and the ACT compounds of α 1
CN110317246B (en) Human MOG epitope peptide, antigen, antibody, application and chemiluminescence kit

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant